-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2021 to Q4 2024.
- Tarsus Pharmaceuticals, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $90.8M, a 57.9% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $304M, a 89% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Costs and Expenses for 2024 was $304M, a 89% increase from 2023.
- Tarsus Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $161M, a 81.4% increase from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)